Tatva Chintan Pharma Chem Ltd. has announced public offering of 4616806 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 1,073.00 per share. The gross proceeds of the issue are expected to be Rs 50,000.01 lakhs.

The company's initial public offer (IPO) will open on 16 July 2021 and is expected to close on 20 July 2021, subject to customary closing conditions. The price band of the issue has been fixed at Rs 1,073.00-1,083.00 per share.

The IPO includes a fresh Issue of 4616806 Equity Shares of the Company at an price of Rs 1,083.00 per Equity Share. The company has fixed the minimum bid lot for the issue at 13 shares with bids in multiples of 13.

Tatva Chintan Pharma Chem Ltd. anticipates using the proceeds of the issue for Funding capital expenditure requirements for expansion of the Dahej Manufacturing Facility Funding capital expenditure requirements for upgradation at the R&D facility in Vadodara General corporate purposes.

JM Financial Ltd.,ICICI Securities Ltd as lead manager(s) & Link Intime India Private Limited is the registrar, to the issue.